Severe extensive ulcerative colitis. Case presentation

Authors

Keywords:

ulcerative colitis, chronic disease, colon.

Abstract

Ulcerative colitis is a chronic recidivist disease of the gastrointestinal tract, evolving by relapses and is one of the intestinal inflammatory diseases. It affects the colon mucosa and sub-mucosa, characterized for an ulcerative process and mucosa exudation.  Chronic diarrhea with blood is the most important symptom. Periods of crisis and remission alternated in its course; there is not a pathognomonic criteria for its definition and its diagnosis is based in a series of clinical, endoscopic and histological criteria. This entity, infrequent in extensive severe form, appears in a patient arriving to the hospital referring having intermittent diarrheas with blood for two years, treated in the health area. He undergone a radiography and colonoscopy, showing the presence of an erythema, mucosa granularity, friability, lost of submucosa vascularization, deep extensive erosions and ulcerations, edema signs, pseudo polyps, haustras lost, stiffness, bleeding, fibrous tracts and presence of luminal exudates.  Severe ulcerative extensive colitis was diagnosed and was prescribed an endovenous medical treatment, continued orally, achieving the disease remission from the clinical and endoscopic point of view.

Downloads

Download data is not yet available.

References

1. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. J Crohns Colitis 2010; 4(1): 7–27. Citado en PubMed; PMID: 21122488.
2. Torreblanca Xiques A. Colitis ulcerativa idiopática. Rev Elect Dr.Zoilo E Marinello Vidaurreta [Internet]. 2015 [citado 05/09/16];40(1). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/115/197

3. Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12(2):265-73. Citado en PubMed; PMID: 23602821.

4. Dignass A, Eliakim R, Magro F, et al. Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version). Rev Gastroenterol Mex. 2014;79(4):263-89. Citado en PubMed; PMID: 25487134.

5. Yamamoto Furusho FK, Bosques Padilla F, de Paula J, Galiano MT, et al. Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn’s and Colitis Organisation. Rev de Gastroenterol de México [Internet]. 2017 [citado 23/10/17]; 82(1): 46-84.Disponible en: https://www.sciencedirect.com/science/article/pii/S0375090616300829


6. Jess T, López A, Andersson M, et al. Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis. Clin Gastroenterol Hepatol. 2014; 12(11):1793-800. Citado en PubMed; PMID: 24907505.

7. Deepak P, Sifuentes H, Sherid M, et al. T-cell non-Hodgkin’s lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-a) inhibitors: results of the REFURBISH study. Am J Gastroenterol. 2013;108(1):99-105. Citado en PubMed; PMID: 23032984.

8.Marulanda H, Otero W, Gómez M. Literature Review and Case Report of Post-Inflammatory Polyps and Inflammatory Bowel Disease. Rev Col Gastroenterol [Internet]. 2017 Mar [citedo 13/11/17];32(1):55-9. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-99572017000100008&lng=en.

9. Morales Polanco S, Waller González LA. Validación del Índice de Severidad Endoscópico de Colitis Ulcerativa para la población mexicana. Endoscopia[Internet]. 2016[citado 23/10/17]; 28(1): 2–8.Disponible en:www.sciencedirect.com/science/article/pii/S0188989316300021.

10. Mayer L, Simian D, Kronberg U, et al. Desarrollo de neoplasia en pacientes con enfermedad inflamatoria intestinal. Rev Med Chile [Internet].2015 [citado 23/10/17] ; 143: 834-40. Disponible en: http://www.scielo.cl/pdf/rmc/v143n7/art02.pdf

11. Dignass A, Eliakim R, Magro F, et al. Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version). Rev Gastroenterol Mex. 2014;79(4):263-89. Citado en PubMed; PMID: 25487134.

12. Paniagua Estévez ME, Pinol Jiménez FN. Enfermedades inflamatorias del intestino. En: Gastroenterología y hepatología clínica [Internet]. La Habana: Ecimed; 2014 [citado 05/09/2016]. p. 1317-1412. Disponible en: http://www.bvs.sld.cu/libros/gastroenterologia_hepatologia_tomo1/gastro_tomo1_completo_nuevo.pdf

Downloads

Published

2020-04-21

How to Cite

1.
Del Valle LLufrío P, Cora Estopiñan S, Prieto Fagundo L, González Báez A, Padrón Fernández S, González Herrera O. Severe extensive ulcerative colitis. Case presentation. Rev Méd Electrón [Internet]. 2020 Apr. 21 [cited 2025 Mar. 12];42(3):1-8. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/3053

Issue

Vol. 42 No. 3 (2020)

Section

Presentation of cases

License

All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.

It allows:

 - Copy and redistribute published material in any medium or format.

 - Adapt the content.

 This will be done under the following terms:

 - Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.

 - Non-commercial use.

 - Recognize the journal where it is published.

 The copyrights of each article are maintained, without restrictions.